Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jeremy J Frens"'
Autor:
Nicholas Rebold, Sara Alosaimy, Jeffrey C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M. Jones, Jeremy J. Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 565-579 (2024)
Abstract Introduction Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers to discharge or who require prolonged parenteral antibiotic cour
Externí odkaz:
https://doaj.org/article/329fe8cb8de8423a9b5e528288ac79f6
Autor:
Amer El Ghali, Sara Allosaimy, Taylor Morrisette, Kyle C Molina, Jeremy J Frens, Ryan W Stevens, Jeannette Bouchard, P Brandon Bookstaver, Michael P Veve, Raaga Vemula, Julie Philley, Nicholas S Rebold, Dana Holger, Ashlan J Kunz Coyne, Abdalhamid M Lagnf, Kristen Lucas, Paige Witucki, Michael J Rybak
Publikováno v:
Open Forum Infectious Diseases. 9
Background Multi-drug resistant (MDR) pathogens are a continuously evolving threat for which there are limited effective treatment modalities. Omadacycline (OMC) is a novel oral and intravenously administered aminomethylcycline with potent in-vitro a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::033aa8143eba6c5ff758297863bb0c79
https://doi.org/10.1093/ofid/ofac492.1251
https://doi.org/10.1093/ofid/ofac492.1251
Publikováno v:
Open Forum Infectious Diseases. 9
Background The importance of effective antibiotic therapy for the treatment of bloodstream infections has been well described. Rapid diagnostic testing platforms like the BioFire® FilmArray® blood culture identification (BCID) have the potential to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::784abaaa6bba039c0f63a9fd18e7d974
https://doi.org/10.1093/ofid/ofac492.810
https://doi.org/10.1093/ofid/ofac492.810
Autor:
Taylor Morrisette, Sara Alosaimy, Abdalhamid M. Lagnf, Jeremy J. Frens, Andrew J. Webb, Michael P. Veve, Ryan Stevens, Jeannette Bouchard, Tristan W. Gore, Iman Ansari, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy.
Antibiotic-resistant Gram-negative bacteria have been associated with substantial morbidity and mortality and have limited treatment options available. Omadacycline (OMC) is an aminomethylcycline antibiotic that has been shown to exhibit broad in vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d3a3671f33cdbee7dc2fd29266bb49
https://doi.org/10.1007/s40121-022-00645-5
https://doi.org/10.1007/s40121-022-00645-5
Autor:
Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Katie Barber, Julie Ann Justo, Kayla Antosz, Travis J Carlson, Jeremy J Frens, Mark Biagi, Wesley D Kufel, William J Moore, Nicholas Mercuro, Brian R Raux, Michael J Rybak
Publikováno v:
Open Forum Infectious Diseases
A multicenter case series of 21 patients were treated with imipenem-cilastatin-relebactam. There were mixed infection sources, with pulmonary infections (11/21,52%) composing the majority. The primary pathogen was Pseudomonas aeruginosa (16/21, 76%),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::966d078d9d00bf0239e9160b42272002
https://pubmed.ncbi.nlm.nih.gov/34901302
https://pubmed.ncbi.nlm.nih.gov/34901302
Publikováno v:
European Journal of Clinical Pharmacology. 76:403-408
The purpose of this study was to compare therapeutic vancomycin trough levels in obese adults when using an original nomogram (phase I) versus a modified nomogram (phase II). This study compared a vancomycin nomogram with a modified vancomycin nomogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a29ec80a267b9ec8dcb20a4b12f7be7
https://doi.org/10.1007/s00228-019-02811-0
https://doi.org/10.1007/s00228-019-02811-0
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 90:50-54
Objectives Staphylococcus aureus bacteremia (SAB) is an important cause of morbidity and mortality. Suboptimal treatment has been associated with poor patient outcomes. Our antimicrobial stewardship program (ASP) evaluated SAB management based on pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61af35c4f616ad2ce5bfb429442e136c
https://doi.org/10.1016/j.diagmicrobio.2017.10.001
https://doi.org/10.1016/j.diagmicrobio.2017.10.001
Autor:
Abdalhamid M Lagnf, Jeremy J Frens, Sara Alosaimy, Melissa Barger, Jeannette Bouchard, Taylor Morrisette, Carly Sigler, Michael J. Rybak, P B Bookstaver, Catessa Howard, Andrew J Webb, Julie V. Philley, Ryan W. Stevens
Publikováno v:
Open Forum Infectious Diseases
Background Omadacycline (OMC) is an aminomethylcycline antibiotic in the tetracycline class that has been Food and Drug Administration-approved for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. OMC has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67e50fb5b38b121a46b76622101a052a
http://europepmc.org/articles/PMC7776159
http://europepmc.org/articles/PMC7776159
Publikováno v:
Open Forum Infectious Diseases
Background Empiric antibiotic therapy for sepsis of unknown origin is typically broad spectrum and covers P. aeruginosa and methicillin-resistant S. aureus (MRSA). Nephrotoxicity is a well-known adverse event of IV vancomycin and literature suggests
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f23fc44d064045810eb5a5596875a9
http://europepmc.org/articles/PMC7776909
http://europepmc.org/articles/PMC7776909
Publikováno v:
Open Forum Infectious Diseases
Background Recently, studies about gram-negative bacteremia have shown that shorter courses and early step-down therapy with oral agents have equivalent outcomes compared to longer courses with intravenous therapy. The question remains, however, as t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea1cf453a24f15f916039cd54739dd45
https://doi.org/10.1093/ofid/ofaa439.315
https://doi.org/10.1093/ofid/ofaa439.315